Cancer Trials Ireland today said that the €3 million cut in its grant is now having a direct impact on potentially breakthrough treatments being available for people in Ireland with cancer.

Congratulations to the University Hospital Limerick cancer trials team which is the first to enrol patients on the t-BRCA cancer trial which could ultimately help women with newly diagnosed or relapsed ovarian cancer. The trial will open in 5 more hospitals around the country. More about the trial here. t-BRCA

A trial to determine if stereotactic body radiation therapy (SBRT) is superior to hypofractionated intensity modulated radiation therapy (IMRT) in the treatment of localised intermediate risk prostate cancer has opened at the Beacon Hospital in Dublin. The trial is sponsored in Ireland by NRG Oncology (International) and Cancer Trials Ireland and will recruit 6 to […]

“By increasing investment in cancer trials infrastructure, we could be offering Irish cancer patients more options and potentially better outcomes. Cancer trials can extend lives and give people a better quality of life. When I am in the clinic with a cancer patient, there are times I want to be able to offer more than […]

Extract from presentation by Eibhlin Mulroe to the Joint Oireachtas Committee on Health on 13th March 2019. “Due to our reduced funding, we have had to decline opening clinically important academic trials in Ireland. These trials would benefit people with a range of cancers including lymphoma, testicular and endometrial cancer. We are unable to be […]